Name | Number of supported studies | Average coverage | |
---|---|---|---|
interneuron | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of FBN3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 834.37 | 649 / 653 | 87% | 11.16 | 526 / 605 |
brain | 90% | 139.43 | 2369 / 2642 | 53% | 2.78 | 376 / 705 |
lung | 94% | 398.58 | 542 / 578 | 23% | 1.39 | 265 / 1155 |
ovary | 36% | 51.51 | 64 / 180 | 76% | 10.97 | 327 / 430 |
kidney | 100% | 834.06 | 89 / 89 | 10% | 2.36 | 92 / 901 |
prostate | 88% | 429.73 | 216 / 245 | 10% | 0.17 | 50 / 502 |
breast | 60% | 123.56 | 277 / 459 | 17% | 1.19 | 185 / 1118 |
uterus | 28% | 37.81 | 47 / 170 | 26% | 3.26 | 118 / 459 |
liver | 27% | 23.14 | 61 / 226 | 17% | 0.56 | 67 / 406 |
skin | 33% | 24.90 | 601 / 1809 | 5% | 0.87 | 23 / 472 |
esophagus | 15% | 26.55 | 219 / 1445 | 18% | 0.76 | 33 / 183 |
stomach | 22% | 24.81 | 79 / 359 | 5% | 0.22 | 14 / 286 |
intestine | 23% | 17.78 | 221 / 966 | 2% | 0.10 | 10 / 527 |
muscle | 22% | 14.66 | 173 / 803 | 0% | 0 | 0 / 0 |
adipose | 13% | 8.35 | 156 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.43 | 5 / 45 |
heart | 8% | 6.51 | 72 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 0.82 | 3 / 258 | 7% | 0.23 | 16 / 230 |
pancreas | 2% | 1.57 | 7 / 328 | 3% | 0.52 | 6 / 178 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.22 | 20 / 504 |
spleen | 2% | 1.15 | 4 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
peripheral blood | 1% | 0.27 | 6 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.30 | 8 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0001527 | Cellular component | microfibril |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | FBN3 |
Protein name | Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Fibrillin 3 Fibrillin-3 |
Synonyms | KIAA1776 |
Description | FUNCTION: [Fibrillin-3]: Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-containing microfibrils provide long-term force bearing structural support. . |
Accessions | ENST00000651877.1 ENST00000600128.6 Q75N90 ENST00000602121.1 ENST00000601281.1 M0QXL8 A8KAY2 Q86YS9 ENST00000601739.5 A0A494C0D8 ENST00000270509.6 M0R2Q5 |